Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody
Dr. Yong Zhang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Huafei Zou
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Ying Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDawna Caballero
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorJose Gonzalez
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorElizabeth Chao
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorGus Welzel
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Weijun Shen
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Danling Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorCorresponding Author
Dr. Peter G. Schultz
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)Search for more papers by this authorCorresponding Author
Dr. Feng Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)Search for more papers by this authorDr. Yong Zhang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Huafei Zou
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Ying Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDawna Caballero
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorJose Gonzalez
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorElizabeth Chao
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorGus Welzel
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Weijun Shen
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorDr. Danling Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
Search for more papers by this authorCorresponding Author
Dr. Peter G. Schultz
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)Search for more papers by this authorCorresponding Author
Dr. Feng Wang
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)
California Institute for Biomedical Research (Calibr), 11119 N. Torrey Pines Road, La Jolla, CA 92037 (USA)Search for more papers by this authorAbstract
Bovine antibody BLV1H12 possesses a unique “stalk–knob” architecture in its ultralong heavy chain CDR3, allowing substitutions of the “knob” domain with protein agonists to generate functional antibody chimeras. We have generated a humanized glucagon-like peptide-1 (GLP-1) receptor agonist antibody by first introducing a coiled-coil “stalk” into CDR3H of the antibody herceptin. Exendin-4 (Ex-4), a GLP-1 receptor agonist, was then fused to the engineered stalk with flexible linkers, and a Factor Xa cleavage site was inserted immediately in front of Ex-4 to allow release of the N-terminus of the fused peptide. The resulting clipped herceptin–Ex-4 fusion protein is more potent in vitro in activating GLP-1 receptors than the Ex-4 peptide. The clipped herceptin–Ex-4 has an extended plasma half-life of approximately four days and sustained control of blood glucose levels for more than a week in mice. This work provides a novel approach to the development of human or humanized agonist antibodies as therapeutics.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Filename | Description |
---|---|
ange_201410049_sm_miscellaneous_information.pdf1.4 MB | miscellaneous_information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1
- 1aH. Zhang, K. Yea, J. Xie, D. Ruiz, I. A. Wilson, R. A. Lerner, Chem. Biol. 2013, 20, 734–741;
- 1bH. Zhang, I. A. Wilson, R. A. Lerner, Proc. Natl. Acad. Sci. USA 2012, 109, 15728–15733;
- 1cA. L. Wu, G. Kolumam, S. Stawicki, Y. Chen, J. Li, J. Zavala-Solorio, K. Phamluong, B. Feng, L. Li, S. Marsters, L. Kates, N. van Bruggen, M. Leabman, A. Wong, D. West, H. Stern, E. Luis, H. S. Kim, D. Yansura, A. S. Peterson, E. Filvaroff, Y. Wu, J. Sonoda, Sci. Transl. Med. 2011, 3, 113ra126.
- 2
- 2aV. R. Doppalapudi, J. Huang, D. Liu, P. Jin, B. Liu, L. Li, J. Desharnais, C. Hagen, N. J. Levin, M. J. Shields, M. Parish, R. E. Murphy, J. Del Rosario, B. D. Oates, J. Y. Lai, M. J. Matin, Z. Ainekulu, A. Bhat, C. W. Bradshaw, G. Woodnutt, R. A. Lerner, R. W. Lappe, Proc. Natl. Acad. Sci. USA 2010, 107, 22611–22616;
- 2bJ. Huang, T. Ishino, G. Chen, P. Rolzin, T. F. Osothprarop, K. Retting, L. Li, P. Jin, M. J. Matin, B. Huyghe, S. Talukdar, C. W. Bradshaw, M. Palanki, B. N. Violand, G. Woodnutt, R. W. Lappe, K. Ogilvie, N. Levin, J. Pharmacol. Exp. Ther. 2013, 346, 270–280.
- 3F. Wang, D. C. Ekiert, I. Ahmad, W. Li, Y. Zhang, O. Bazirgan, A. Torkamani, T. Raudsepp, W. Mwangi, M. F. Criscitiello, I. A. Wilson, P. G. Schultz, V. V. Smider, Cell 2013, 153, 1379–1393.
- 4
- 4aY. Zhang, D. Wang, L. de Lichtervelde, S. B. Sun, V. V. Smider, P. G. Schultz, F. Wang, Angew. Chem. Int. Ed. 2013, 52, 8295–8298; Angew. Chem. 2013, 125, 8453–8456;
- 4bY. Zhang, D. Wang, G. Welzel, Y. Wang, P. G. Schultz, F. Wang, ACS Chem. Biol. 2013, 8, 2117–2121;
- 4cT. Liu, Y. Liu, Y. Wang, M. Hull, P. G. Schultz, F. Wang, J. Am. Chem. Soc. 2014, 136, 10557–10560.
- 5Y. Zhang, D. Goswami, D. Wang, T. S. Wang, S. Sen, T. J. Magliery, P. R. Griffin, F. Wang, P. G. Schultz, Angew. Chem. Int. Ed. 2014, 53, 132–135; Angew. Chem. 2014, 126, 136–139.
- 6
- 6aE. O. Saphire, P. W. Parren, R. Pantophlet, M. B. Zwick, G. M. Morris, P. M. Rudd, R. A. Dwek, R. L. Stanfield, D. R. Burton, I. A. Wilson, Science 2001, 293, 1155–1159;
- 6bR. Pejchal, L. M. Walker, R. L. Stanfield, S. K. Phogat, W. C. Koff, P. Poignard, D. R. Burton, I. A. Wilson, Proc. Natl. Acad. Sci. USA 2010, 107, 11483–11488.
- 7
- 7aJ. Baselga, D. Tripathy, J. Mendelsohn, S. Baughman, C. C. Benz, L. Dantis, N. T. Sklarin, A. D. Seidman, C. A. Hudis, J. Moore, P. P. Rosen, T. Twaddell, I. C. Henderson, L. Norton, J. Clin. Oncol. 1996, 14, 737–744;
- 7bM. A. Bookman, K. M. Darcy, D. Clarke-Pearson, R. A. Boothby, I. R. Horowitz, J. Clin. Oncol. 2003, 21, 283–290.
- 8
- 8aJ. Eng, W. A. Kleinman, L. Singh, G. Singh, J. P. Raufman, J. Biol. Chem. 1992, 267, 7402–7405;
- 8bA. A. Young, B. R. Gedulin, S. Bhavsar, N. Bodkin, C. Jodka, B. Hansen, M. Denaro, Diabetes 1999, 48, 1026–1034.
- 9D. J. Drucker, M. A. Nauck, Lancet 2006, 368, 1696–1705.
- 10
- 10aL. B. Knudsen, P. F. Nielsen, P. O. Huusfeldt, N. L. Johansen, K. Madsen, F. Z. Pedersen, H. Thogersen, M. Wilken, H. Agerso, J. Med. Chem. 2000, 43, 1664–1669;
- 10bM. B. DeYoung, L. MacConell, V. Sarin, M. Trautmann, P. Herbert, Diabetes Technol. Ther. 2011, 13, 1145–1154;
- 10cJ. B. Buse, M. Nauck, T. Forst, W. H. Sheu, S. K. Shenouda, C. R. Heilmann, B. J. Hoogwerf, A. Gao, M. K. Boardman, M. Fineman, L. Porter, G. Schernthaner, Lancet 2013, 381, 117–124;
- 10dR. E. Pratley, M. A. Nauck, A. H. Barnett, M. N. Feinglos, F. Ovalle, I. Harman-Boehm, J. Ye, R. Scott, S. Johnson, M. Stewart, J. Rosenstock, The Lancet. Diabetes & Endocrinology 2014, 2, 289–297; Endocrinology 2014, 2, 289–297;
- 10eK. M. Dungan, S. T. Povedano, T. Forst, J. G. Gonzalez, C. Atisso, W. Sealls, J. L. Fahrbach, Lancet 2014, 0, 0;
- 10fR. L. O’Connor-Semmes, J. Lin, R. J. Hodge, S. Andrews, J. Chism, A. Choudhury, D. J. Nunez, Clin. Pharmacol. Ther. 2014, 0, 0.
- 11
- 11aJ. Baselga, D. Tripathy, J. Mendelsohn, S. Baughman, C. C. Benz, L. Dantis, N. T. Sklarin, A. D. Seidman, C. A. Hudis, J. Moore, P. P. Rosen, T. Twaddell, I. C. Henderson, L. Norton, Semin. Oncol. 1999, 26, 78–83;
- 11bM. M. Goldenberg, Clin. Ther. 1999, 21, 309–318;
- 11cS. Shak, Semin. Oncol. 1999, 26, 71–77;
- 11dH. S. Cho, K. Mason, K. X. Ramyar, A. M. Stanley, S. B. Gabelli, D. W. Denney, Jr., D. J. Leahy, Nature 2003, 421, 756–760.
- 12S. Runge, H. Thogersen, K. Madsen, J. Lau, R. Rudolph, J. Biol. Chem. 2008, 283, 11340–11347.
- 13
- 13aK. L. Armour, M. R. Clark, A. G. Hadley, L. M. Williamson, Eur. J. Immunol. 1999, 29, 2613–2624;
10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- 13bR. L. Shields, A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, J. A. Fox, L. G. Presta, J. Biol. Chem. 2001, 276, 6591–6604.
- 14
- 14aF. Selis, R. Schrepfer, R. Sanna, S. Scaramuzza, G. Tonon, S. Dedoni, P. Onali, G. Orsini, S. Genovese, Results Pharma Sci. 2012, 2, 58–65;
- 14bW. Glaesner, A. M. Vick, R. Millican, B. Ellis, S. H. Tschang, Y. Tian, K. Bokvist, M. Brenner, A. Koester, N. Porksen, G. Etgen, T. Bumol, Diabetes/Metab. Res. Rev. 2010, 26, 287–296;
- 14cB. Rolin, M. O. Larsen, C. F. Gotfredsen, C. F. Deacon, R. D. Carr, M. Wilken, L. B. Knudsen, Am. J. Physiol. Endocrinology Metabolism 2002, 283, E 745–752;
- 14dW. Bao, L. J. Holt, R. D. Prince, G. X. Jones, K. Aravindhan, M. Szapacs, A. M. Barbour, L. J. Jolivette, J. J. Lepore, R. N. Willette, E. DeAngelis, B. M. Jucker, Cardiovasc. Diabetol. 2013, 12, 148.
- 15
- 15aC. Lundegaard, O. Lund, M. Nielsen, Bioinformatics 2008, 24, 1397–1398;
- 15bJ. J. Calis, M. Maybeno, J. A. Greenbaum, D. Weiskopf, A. D. De Silva, A. Sette, C. Kesmir, B. Peters, PLoS Comput. Biol. 2013, 9, e 1003266.
Citing Literature
This is the
German version
of Angewandte Chemie.
Note for articles published since 1962:
Do not cite this version alone.
Take me to the International Edition version with citable page numbers, DOI, and citation export.
We apologize for the inconvenience.